FDA Inspection 1207686 — Aizant Drug Research Solutions Private Ltd.
The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on Apr 28, 2023 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hyderabad (India)